Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07020546 · ClinicalTrials.gov registry record · NA

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

A NA study of Infertility and in Vitro Fertilization, sponsored by Generation Next Fertility.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT07020546 is a NA study of Infertility and in Vitro Fertilization that is actively recruiting participants, run by Generation Next Fertility. The registered enrollment target is 180 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07020546, a NA study of Infertility and in Vitro Fertilization, is actively recruiting participants, sponsored by Generation Next Fertility.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Interventions

  • PROCEDURE Ovarian Platelet-rich plasma (PRP) injections

Study Locations (1)

New York

  • Generation Next Fertility - New York

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-07-08
Est. Completion 2026-08-30
Phase NA

Sponsor

Generation Next Fertility

2 total trials

What the Registry Record Tells You About NCT07020546

The ClinicalTrials.gov registry entry for NCT07020546 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Generation Next Fertility, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Ovarian Platelet-rich plasma (PRP) injections is the first listed.

NCT07020546 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07020546 about?

NCT07020546 is a clinical study titled "Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score". Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

What is the current status of trial NCT07020546?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-07-08. Estimated completion is 2026-08-30.

What conditions does trial NCT07020546 study?

This clinical trial studies the following conditions: Infertility, in Vitro Fertilization, Poor Ovarian Reserve, Embryo Growth Disorder.

What interventions are being tested in trial NCT07020546?

The interventions under investigation include: Ovarian Platelet-rich plasma (PRP) injections (PROCEDURE).

Who is sponsoring clinical trial NCT07020546?

This trial is sponsored by Generation Next Fertility, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07020546 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.